Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Akela Pharma Inc. AKLPF

Healthcare Biotechnology
"Akela Pharma Inc is engaged in providing contract services comprised of pharmaceutical formulation research and development, pre-clinical, clinical and commercial drug manufacturing, product development and patent litigation support."


GREY:AKLPF - Post by User

Akela Pharma Inc. > Year End
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Comment by Biostocks01on Apr 03, 2011 5:56pm
315 Views
Post# 18379513

RE: RE: RE: RE: RE: RE: RE: RE: Year End

RE: RE: RE: RE: RE: RE: RE: RE: Year End
I hope that you are right for the Asian partner.

I remember that last summer, we received near 2M from our Asian partner for advances the studies of phase 3 of our  Fentanyl TAIFUN® product .

Do You have any idea which is Horace S.Boone??

Mar 25/11 Mar 25/11 Boone, Horace Shepard Direct Ownership Common Shares 00 - Opening Balance-Initial SEDI Report
I also noticed the transactions coming from TD. Normally the strong volumes are warning of one major events...Maybe this Asian partner with an upfront payment.

Thank you for your comments it is interesting to have a few activities here...hope that other people are going to make post too

Bio
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities